BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1517 related articles for article (PubMed ID: 19248107)

  • 1. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
    Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraspanin CD151 is expressed in osteoarthritic cartilage and is involved in pericellular activation of pro-matrix metalloproteinase 7 in osteoarthritic chondrocytes.
    Fujita Y; Shiomi T; Yanagimoto S; Matsumoto H; Toyama Y; Okada Y
    Arthritis Rheum; 2006 Oct; 54(10):3233-43. PubMed ID: 17009258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
    Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
    Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids.
    Garvican ER; Vaughan-Thomas A; Redmond C; Gabriel N; Clegg PD
    J Orthop Res; 2010 Mar; 28(3):370-8. PubMed ID: 19777546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
    Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
    J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of C-C chemokines and their receptors in osteoarthritis.
    Yuan GH; Masuko-Hongo K; Sakata M; Tsuruha J; Onuma H; Nakamura H; Aoki H; Kato T; Nishioka K
    Arthritis Rheum; 2001 May; 44(5):1056-70. PubMed ID: 11352237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.
    Kim HA; Cho ML; Choi HY; Yoon CS; Jhun JY; Oh HJ; Kim HY
    Arthritis Rheum; 2006 Jul; 54(7):2152-63. PubMed ID: 16802353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
    Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
    Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis.
    Hayashida M; Okazaki K; Fukushi J; Sakamoto A; Iwamoto Y
    Arthritis Rheum; 2009 Mar; 60(3):708-16. PubMed ID: 19248099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes.
    Hui A; Min WX; Tang J; Cruz TF
    Arthritis Rheum; 1998 May; 41(5):869-76. PubMed ID: 9588740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
    Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
    Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
    van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
    Tchetina EV; Squires G; Poole AR
    J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta.
    Kaiser M; Haag J; Söder S; Bau B; Aigner T
    Arthritis Rheum; 2004 Nov; 50(11):3535-40. PubMed ID: 15529348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.